Habbab, W.; Aoudé, I.; Palangi, F.; Abdulla, S.; Ahmed, T.
The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons. Int. J. Mol. Sci. 2019, 20, 844.
https://doi.org/10.3390/ijms20040844
AMA Style
Habbab W, Aoudé I, Palangi F, Abdulla S, Ahmed T.
The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons. International Journal of Molecular Sciences. 2019; 20(4):844.
https://doi.org/10.3390/ijms20040844
Chicago/Turabian Style
Habbab, Wesal, Imad Aoudé, Freshteh Palangi, Sara Abdulla, and Tariq Ahmed.
2019. "The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons" International Journal of Molecular Sciences 20, no. 4: 844.
https://doi.org/10.3390/ijms20040844
APA Style
Habbab, W., Aoudé, I., Palangi, F., Abdulla, S., & Ahmed, T.
(2019). The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons. International Journal of Molecular Sciences, 20(4), 844.
https://doi.org/10.3390/ijms20040844